Verastem's Ovarian Cancer Drug Showing Promise, Analyst Upgrades Stock
June 15, 2023 at 14:03 PM EDT
Mizuho Securitieshas upgradedVerastem Inc(NASDAQ: VSTM) from Neutral to Buy with a price target of $36, up from $24, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.